Sandra Radenković

646 total citations
17 papers, 453 citations indexed

About

Sandra Radenković is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Sandra Radenković has authored 17 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Sandra Radenković's work include Immune Cell Function and Interaction (6 papers), Protease and Inhibitor Mechanisms (3 papers) and T-cell and B-cell Immunology (3 papers). Sandra Radenković is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Protease and Inhibitor Mechanisms (3 papers) and T-cell and B-cell Immunology (3 papers). Sandra Radenković collaborates with scholars based in Serbia, Czechia and Spain. Sandra Radenković's co-authors include Gordana Konjević, Vladimir Jurišić, Kristina Gopčević, Katarina Mirjačić Martinović, Ana Vuletić, Marina Nikitović, I Spuz̈ić, Predrag Stevanović, Branislav Rovčanin and Aleksandra Isaković and has published in prestigious journals such as European Journal of Cancer, Biomedicine & Pharmacotherapy and Advances in experimental medicine and biology.

In The Last Decade

Sandra Radenković

14 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Radenković Serbia 9 127 127 114 111 57 17 453
Kunyuan Guo China 13 202 1.6× 91 0.7× 55 0.5× 118 1.1× 67 1.2× 49 499
Xin Jing China 12 305 2.4× 173 1.4× 106 0.9× 135 1.2× 56 1.0× 28 554
Kyeongmin Kim South Korea 10 187 1.5× 90 0.7× 93 0.8× 41 0.4× 88 1.5× 33 454
Balaji Ramachandran India 14 298 2.3× 162 1.3× 110 1.0× 79 0.7× 50 0.9× 23 601
Nataša Todorović‐Raković Serbia 13 280 2.2× 342 2.7× 117 1.0× 115 1.0× 63 1.1× 43 602
Min Guo China 11 223 1.8× 74 0.6× 134 1.2× 83 0.7× 51 0.9× 46 403
Shixin Xiang China 12 271 2.1× 217 1.7× 121 1.1× 136 1.2× 92 1.6× 17 540
Keiji Ozeki Japan 13 147 1.2× 107 0.8× 61 0.5× 77 0.7× 81 1.4× 57 527

Countries citing papers authored by Sandra Radenković

Since Specialization
Citations

This map shows the geographic impact of Sandra Radenković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Radenković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Radenković more than expected).

Fields of papers citing papers by Sandra Radenković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Radenković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Radenković. The network helps show where Sandra Radenković may publish in the future.

Co-authorship network of co-authors of Sandra Radenković

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Radenković. A scholar is included among the top collaborators of Sandra Radenković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Radenković. Sandra Radenković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Mojić, Marija, et al.. (2025). Innate lymphoid cells: Dual roles and therapeutic opportunities in breast cancer. Immunology Letters. 276. 107051–107051.
3.
Stojanović-Rundić, Suzana, Dušica Gavrilović, Radmila Janković, et al.. (2025). Dose Escalation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Short-Term Efficacy and Toxicity of VMAT–SIB vs. 3D-CRT. Medicina. 61(3). 483–483.
4.
Milutinović, Milena, et al.. (2025). Modulation of the Main Resistance-Associated ABC Transporter’s Expression by Plant Flavonol Isorhamnetin. Pharmaceuticals. 18(4). 494–494. 1 indexed citations
5.
Radenković, Sandra, et al.. (2021). Evaluation of Cyclin D1 expression by western blotting methods and immunohistochemistry in breast cancer patients.. PubMed. 26(2). 475–482. 4 indexed citations
6.
Radenković, Sandra, et al.. (2019). Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma multiforme.. PubMed. 22(4). 1061–1067. 21 indexed citations
7.
Radenković, Sandra, Gordana Konjević, Dušica Gavrilović, et al.. (2018). pSTAT3 expression associated with survival and mammographic density of breast cancer patients. Pathology - Research and Practice. 215(2). 366–372. 16 indexed citations
8.
Jurišić, Vladimir, Sandra Radenković, & Gordana Konjević. (2015). The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects. Advances in experimental medicine and biology. 867. 115–124. 213 indexed citations
9.
Radenković, Sandra, Gordana Konjević, Aleksandra Isaković, et al.. (2014). HER2-positive breast cancer patients: correlation between mammographic and pathological findings. Radiation Protection Dosimetry. 162(1-2). 125–128. 31 indexed citations
10.
Radenković, Sandra, et al.. (2013). Values of MMP-2 and MMP-9 in Tumor Tissue of Basal-Like Breast Cancer Patients. Cell Biochemistry and Biophysics. 68(1). 143–152. 42 indexed citations
11.
Radenković, Sandra, Zorica Milošević, Gordana Konjević, et al.. (2012). Lactate dehydrogenase, Catalase, and Superoxide dismutase in Tumor Tissue of Breast Cancer Patients in Respect to Mammographic Findings. Cell Biochemistry and Biophysics. 66(2). 287–295. 35 indexed citations
12.
Konjević, Gordana, Vladimir Jurišić, Ana Vuletić, et al.. (2012). Investigation of NK cell function and their modulation in different malignancies. Immunologic Research. 52(1-2). 139–156. 51 indexed citations
13.
Radenković, Sandra, et al.. (2011). 5108 POSTER Association of Decreased NK Cell Activity and IFNgamma Expression With pSTAT Dysregulation in Breast Cancer Patients. European Journal of Cancer. 47. S362–S362. 1 indexed citations
14.
Konjević, Gordana, et al.. (2011). Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients.. PubMed. 16(2). 219–26. 11 indexed citations
15.
Gopčević, Kristina, Branislav Rovčanin, Dušan Kekić, & Sandra Radenković. (2010). Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction. Molecular and Cellular Biochemistry. 350(1-2). 163–168. 7 indexed citations
16.
Konjević, Gordana, Katarina Mirjačić Martinović, Ana Vuletić, & Sandra Radenković. (2010). Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction. Biomedicine & Pharmacotherapy. 64(10). 663–671. 19 indexed citations
17.
Radenković, Sandra, et al.. (2010). Gelatinases A and B activities in the serum of patients with various coronary artery disease stages. Vojnosanitetski pregled. 67(10). 825–830. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kunyuan Guo Breakdown of academic impact, for papers by Xin Jing Breakdown of academic impact, for papers by Kyeongmin Kim Breakdown of academic impact, for papers by Balaji Ramachandran Breakdown of academic impact, for papers by Nataša Todorović‐Raković Breakdown of academic impact, for papers by Min Guo Breakdown of academic impact, for papers by Shixin Xiang Breakdown of academic impact, for papers by Keiji Ozeki
Rankless by CCL
2026